2020 Global life sciences outlook
Creating new value | Building blocks for the future
Gene therapies, intelligent drug discovery and development, consumer wearables, telemedicine, and more—what are some of the drivers transforming the life sciences sector? How can biopharma and medtech organizations create new value in 2020, while tackling various challenges?
Key factors to improve drug launches
Why drug launches miss market expectations and what to do about it
Getting a drug launch right is critical for its overall success. And many factors that contribute to lower-than-expected sales at launch can be mitigated through planning and disciplined execution.
RWE focus is shifting to R&D, early investments begin to payoff
How can others catch up?
Companies that have invested in mature RWE capabilities are seeing returns; others are behind. Results from Deloitte’s third RWE benchmarking study reveal how companies still building their capabilities can catch up.
Regulation in Life Sciences
Turning complexity into opportunity
Stay ahead of the curve when it comes to regulatory policy in Life Sciences. Here you'll find a range of tools on a variety of topics from around the globe that provide critical insight and advice, helping you to anticipate change and plan ahead.